Company
United StatesPublic company, NYSE: SNNSmith and Nephew (NYSE: SNN), Goodlettsville, TN – FDA Inspections
Inspection records and compliance data for Smith and Nephew in Goodlettsville, Tennessee. 2 FDA inspections on record, last inspected December 06, 2011. Publicly traded as NYSE: SNN.
Company Profile
This profile covers Smith and Nephew based in Goodlettsville, Tennessee, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected September 22, 2010. Last inspected December 6, 2011.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 6, 2011 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 756032 |
| September 22, 2010 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 681682 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Smith and Nephew
Stock ticker
SNN
Exchange
NYSE
Share price
$32.03
Market cap
$13.4B
Price as of
November 6, 2026
FEI Number
3004750106
Address
3050 Business Park Cir Ste 402, Goodlettsville, Tennessee 37072, United States
Country
United States
ID: 1862b9c1-b54b-49f8-a468-cabc95564ee3